U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07721233) titled 'Virtual-reality Induced Immune Modulation in Allergic Patients' on July 17.
Brief Summary: This study investigates whether immersive virtual reality (VR) exposure to allergen-related stimuli can modulate behavioural, neurophysiological, psychophysiological, and immune responses in adults with bee or wasp venom allergy.
The study consists of two parts. In Part 1, adults with documented bee or wasp venom allergy and healthy volunteers will undergo immersive VR exposure in a realistic picnic environment. All participants will first be exposed to a control condition involving virtual flies. They will then be randomly assigned to exposu...